Global Information
회사소개 | 문의 | 비교리스트

세계의 유아용 조제분유용 프리바이오틱스 시장 : 산업 동향과 예측

Global Prebiotics for Infant Formula Market - Industry Trends and Forecast To 2027

리서치사 Data Bridge Market Research Private Limited
발행일 2019년 12월 상품 코드 921306
페이지 정보 영문
가격
US $ 4,800 ₩ 5,883,000 Web Access (Single User License) - Read Only help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste, 다운로드 및 인쇄가 불가합니다.
US $ 7,000 ₩ 8,579,000 Web Access (Enterprise License) - Printable/Downloadable help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste, 다운로드 및 인쇄가 가능합니다. 인쇄 횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 유아용 조제분유용 프리바이오틱스 시장 : 산업 동향과 예측 Global Prebiotics for Infant Formula Market - Industry Trends and Forecast To 2027
발행일 : 2019년 12월 페이지 정보 : 영문

세계의 유아용 조제분유용 프리바이오틱스 시장은 2020-2027년의 예측기간 중 상당한 CAGR이 예측됩니다.

세계의 유아용 조제분유용 프리바이오틱스(Prebiotics for Infant Formula) 시장에 대해 조사 분석했으며, 시장 개요, 부문별 시장 분석, 지역별 시장 분석, 경쟁 상황, 주요 기업 등에 대한 체계적인 정보를 제공합니다.

목차

제1장 서론

제2장 시장 세분화

제3장 주요 요약

제4장 중요 인사이트

제5장 진화

  • 유아용 조제분유의 진화
  • 프리바이오틱스 조제분유의 진화

제6장 규제와 품질 요건

  • 규제
  • 품질 요건

제7장 임상시험

  • NCT03994315
  • NCT03884309
  • NCT02594683
  • NCT03661736
  • NCT03666572
  • NCT03866837
  • NCT03476889

제8장 유아용 조제분유 브랜드 애널리스트

  • ABBOTT
  • MEAD JOHNSON & COMPANY, LLC
  • DANONE NUTRICIA
  • NESTLE
  • PERRIGO NUTRITIONALS
  • HOCHDORF HOLDING AG

제9장 시장 개요

  • 성장 촉진요인
  • 성장 억제요인
  • 시장 기회
  • 과제

제10장 세계의 유아용 조제분유용 프리바이오틱스 시장 : 종류별

  • 개요
  • 모유 올리고당(HMOS)
  • 프락토올리고당(FOS)
  • 갈락토올리고당(GOS)
  • 이눌린
  • 폴리덱스트로스(PDX)
  • 만난올리고당(MOS)
  • 락툴로오스(LOS)

제11장 세계의 유아용 조제분유용 프리바이오틱스 시장 : 유래별

  • 개요
  • 식물 및 야채
  • 박테리아
  • 균류
  • 조류
  • 기타

제12장 세계의 유아용 조제분유용 프리바이오틱스 시장 : 등급별

  • 개요
  • 무기
  • 유기

제13장 세계의 유아용 조제분유용 프리바이오틱스 시장 : 형태별

  • 개요
  • 분말
  • 액체

제14장 세계의 유아용 조제분유용 프리바이오틱스 시장 : 제품 종류별

  • 개요
  • 영아용(0-6개월령)
  • 특수용
  • 이유용(6-12개월령)
  • 유아용(12개월령 이상)

제15장 세계의 유아용 조제분유용 프리바이오틱스 시장 : 유아 연령별

  • 개요
  • 6-12개월
  • 0-6개월
  • 1-3세

제16장 세계의 유아용 조제분유용 프리바이오틱스 시장 : 지역별

  • 개요
  • 북미
  • 아시아태평양
  • 유럽
  • 남미
  • 중동 및 아프리카

제17장 세계의 유아용 조제분유용 프리바이오틱스 시장 : 기업 상황

  • 기업 점유율 분석 : 세계
  • 기업 점유율 분석 : 북미
  • 기업 점유율 분석 : 아시아태평양
  • 기업 점유율 분석 : 유럽
  • 기업 점유율 분석 : 중동 및 아프리카

제18장 기업 개요

  • ROYAL FRIESLANDCAMPINA N.V.
  • CARGILL, INCORPORATED
  • INGREDION INCORPORATED
  • BENEO
  • FONTERRA CO-OPERATIVE GROUP
  • BIOSYNTH CARBOSYNTH
  • COSUCRA
  • DANA DAIRY GROUP
  • DEXTRA LABORATORIES LIMITED
  • DUPONT
  • ELICITYL SA
  • GLYCOM A/S
  • GLYCOSYN LLC
  • JENNEWEIN BIOTECHNOLOGIE GMBH
  • NEW FRANCISCO(YUNFU CITY) BIOTECHNOLOGY CORPORATION LIMITED
  • ROYAL COSUN
  • TEREOS
  • ZUCHEM INC.

제19장 앙케이트

제20장 관련 보고서

KSM 20.02.07

LIST OF FIGURES

  • FIGURE 1 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: SEGMENTATION
  • FIGURE 2 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: DATA TRIANGULATION
  • FIGURE 3 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: DROC ANALYSIS
  • FIGURE 4 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 9 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: SEGMENTATION
  • FIGURE 10 STRINGENT REGULATIONS SET BY GOVERNMENT FOR FOOD & DRUG DEVELOPMENT IS EXPECTED TO DRIVE THE GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 11 HUMAN MILK OLIGOSACCHARIDES (HMOS) IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET IN 2020 & 2027
  • FIGURE 12 TO ENSURE THE QUALITY, THE MANUFACTURERS CAN IMPLEMENT THE FOLLOWING QUALITY STANDARDS PROCEDURE OR STEPS:
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITY AND CHALLENGE OF GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET
  • FIGURE 14 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE, 2019
  • FIGURE 15 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY SOURCE, 2019
  • FIGURE 16 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY GRADE, 2019
  • FIGURE 17 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY FORM, 2019
  • FIGURE 18 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY PRODUCT TYPE, 2019
  • FIGURE 19 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY INFANT AGE, 2019
  • FIGURE 20 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: SNAPSHOT (2019)
  • FIGURE 21 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY GEOGRAPHY (2019)
  • FIGURE 22 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY GEOGRAPHY (2020 & 2027)
  • FIGURE 23 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY GEOGRAPHY (2019 & 2027)
  • FIGURE 24 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE (2020-2027)
  • FIGURE 25 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
  • FIGURE 26 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: SNAPSHOT (2019)
  • FIGURE 27 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019)
  • FIGURE 28 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 29 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 30 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE (2020-2027)
  • FIGURE 31 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET: SNAPSHOT (2019)
  • FIGURE 32 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019)
  • FIGURE 33 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 34 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 35 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE (2020-2027)
  • FIGURE 36 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET: SNAPSHOT (2019)
  • FIGURE 37 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019)
  • FIGURE 38 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 39 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 40 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE (2020-2027)
  • FIGURE 41 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: SNAPSHOT (2019)
  • FIGURE 42 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019)
  • FIGURE 43 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 44 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 45 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE (2020-2027)
  • FIGURE 46 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET: SNAPSHOT (2019)
  • FIGURE 47 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019)
  • FIGURE 48 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 49 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 50 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE (2020-2027)
  • FIGURE 51 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 52 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 53 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 54 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 55 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET: COMPANY SHARE 2019 (%)

Global prebiotics for infant formula market is projected to register a substantial CAGR in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation

By Type (Human Milk Oligosaccharides (HMOS), Galactooligosaccharides (GOS), Fructooligosaccharides (FOS), Mannan-Oligosaccharides (MOS), Polydextrose (PDX), Lactulose (LOS), Inulin), Source (Bacteria, Algae, Fungi, Plants & Vegetables), Grade (Inorganic, Organic), Form (Powder, Liquid), Product Type (Standard Formula, Toddler Formula, Follow Up Formula, Special Formula), Infant Age (0-6 Months, 6-12 Months, 1-3 Years), By Geography (North America, Asia-Pacific, Europe, South America, Middle East & Africa), Market Trends and Forecast to 2027

Some of the major factors contributing to the growth of the global prebiotics for infant formula market:

  • Rising Number from Preterm/Premature Babies
  • Increased Research Initiative for New Product Development

Key Market Players

The key market players for global prebiotics for infant formula market are listed below:

  • Jennewein Biotechnologie GmbH
  • zuChem Inc
  • Biosynth Carbosynth
  • ElicitylSA
  • Dextra Laboratories Limited
  • Glycom A/S
  • Tereos
  • Ingredion Incorporated
  • Royal FrieslandCampina N.V
  • Sudzucker AG
  • Cargill, Incorporated
  • Fonterra Co-operative Group
  • Royal Cosun
  • COSUCRA
  • New Francisco (Yunfu City) Biotechnology Corporation Limited
  • Dana Dairy Group
  • Glycosyn LLC
  • DuPont

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.6 DBMR MARKET POSITION GRID
  • 2.7 MULTIVARIATE MODELING
  • 2.8 PRODUCT TIMELINE CURVE
  • 2.9 SECONDARY SOURCES
  • 2.10 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 EVOLUTION

  • 5.1 EVOLUTION OF INFANT FORMULA
  • 5.2 EVOLUTION OF PREBIOTICS FORMULA

6 REGULATIONS & QUALITY REQUIREMENTS

  • 6.1 REGULATIONS
    • 6.1.1 FDA
      • 6.1.1.1 GRAS NOTICE NO. GRN 000849
      • 6.1.1.2 GRAS NOTICE NO. GRN 00859
      • 6.1.1.3 GRAS NOTICE NO. GRN 000797
      • 6.1.1.4 GRAS NOTICE NO. GRN 000766
      • 6.1.1.5 GRAS Notice No. GRN 000749
      • 6.1.1.6 GRAS Notice No. GRN 000735
      • 6.1.1.7 GRAS Notice No. GRN 000729
      • 6.1.1.8 GRAS Notice No. GRN 000717
      • 6.1.1.9 GRAS Notice No. GRN 000721
      • 6.1.1.10 GRAS Notice No. GRN 000659
      • 6.1.1.11 GRAS Notice No. GRN 000650
      • 6.1.1.12 GRAS Notice No. GRN 000623
      • 6.1.1.13 GRAS Notice No. GRN 000620
    • 6.1.2 EUROPEAN UNION
      • 6.1.2.1 COMMISSION DIRECTIVE 2006/141/EC
    • 6.1.3 AUSTRALIA NEW ZEALAND FOOD STANDARDS CODE
      • 6.1.3.1 STANDARD 2.9.1
      • 6.1.3.2 STANDARD 2.9.2
      • 6.1.3.3 STANDARD 2.9.3
  • 6.2 QUALITY REQUIREMENTS

7 CLINICAL TRIALS

  • 7.1 NCT03994315
  • 7.2 NCT03884309
  • 7.3 NCT02594683
  • 7.4 NCT03661736
  • 7.5 NCT03666572
  • 7.6 NCT03866837
  • 7.7 NCT03476889

8 INFANT FORMULA BRAND ANALYSTS

  • 8.1 ABBOTT
  • 8.2 MEAD JOHNSON & COMPANY, LLC
  • 8.3 DANONE NUTRICIA
  • 8.4 NESTLE
  • 8.5 PERRIGO NUTRITIONALS
  • 8.6 HOCHDORF HOLDING AG

9 MARKET OVERVIEW

  • 9.1 DRIVERS
    • 9.1.1 RISING NUMBER FROM PRETERM/PREMATURE BABIES
    • 9.1.2 INCREASED RESEARCH INITIATIVE FOR NEW PRODUCT DEVELOPMENT
    • 9.1.3 HEALTH BENEFITS ASSOCIATED WITH PREBIOTICS
    • 9.1.4 GROWING CONCERN AND DEMAND FOR THE HEALTHY BABY FOOD
    • 9.1.5 RISING POPULATION OF INFANT
  • 9.2 RESTRAINTS
    • 9.2.1 STRINGENT REGULATION AND APPROVAL CRITERIA SET BY GOVERNMENTS
    • 9.2.2 RISING AWARENESS TOWARDS MOTHER FEEDING FOR INFANT
  • 9.3 OPPORTUNITIES
    • 9.3.1 RAPID DEVELOPMENT IN CHICORY ROOT BASED PREBIOTICS
    • 9.3.2 EMERGING DEMAND IN DEVELOPING NATIONS
    • 9.3.3 STRENGTHENING TRADE RELATIONSHIP BETWEEN DIFFERENT NATIONS
  • 9.4 CHALLENGE
    • 9.4.1 RISING NUMBER OF PRODUCT RECALLS FOR INFANT FORMULA DUE TO CONTAMINATION

10 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE

  • 10.1 OVERVIEW
  • 10.2 HUMAN MILK OLIGOSACCHARIDES (HMOS)
    • 10.2.1 FUCOSYLLACTOSE
      • 10.2.1.1 NEUTRAL FUCOSYLATE OLIGOSACCHARIDES
      • 10.2.1.2 NON-FUCOSYLATED OLIGOSACCHARIDES
    • 10.2.2 LACTO-N- TETRAOSE (LNT) & LACTO-N-NEOTETRAOSE (LNNT)
    • 10.2.3 SIALYLLACTOSE
  • 10.3 FRUCTOOLIGOSACCHARIDES (FOS)
    • 10.3.1 LONG CHAIN FOS (LCFOS)
    • 10.3.2 SINGLE CHAIN FOS (SCFOS)
  • 10.4 GALACTOOLIGOSACCHARIDES (GOS)
    • 10.4.1 LACTOSE DERIVED
    • 10.4.2 GALACTOSE DERIVED
  • 10.5 INULIN
  • 10.6 POLYDEXTROSE (PDX)
  • 10.7 MANNAN-OLIGOSACCHARIDES (MOS)
  • 10.8 LACTULOSE (LOS)

11 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE

  • 11.1 OVERVIEW
  • 11.2 PLANTS & VEGETABLES
    • 11.2.1 WHEAT
    • 11.2.2 CHICORY ROOT
    • 11.2.3 BANANAS
    • 11.2.4 LEEKS
    • 11.2.5 TOMATOES
    • 11.2.6 OTHERS
  • 11.3 BACTERIA
  • 11.4 FUNGI
  • 11.5 ALGAE
  • 11.6 OTHERS

12 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE

  • 12.1 OVERVIEW
  • 12.2 INORGANIC
  • 12.3 ORGANIC

13 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM

  • 13.1 OVERVIEW
  • 13.2 POWDER
  • 13.3 LIQUID

14 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE

  • 14.1 OVERVIEW
  • 14.2 STANDARD FORMULA
  • 14.3 SPECIAL FORMULA
  • 14.4 FOLLOW UP FORMULA
  • 14.5 TODDLER FORMULA

15 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE

  • 15.1 OVERVIEW
  • 15.2 6-12 MONTHS
  • 15.3 0-6 MONTHS
  • 15.4 1-3 YEARS

16 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY GEOGRAPHY

  • 16.1 OVERVIEW
  • 16.2 NORTH AMERICA
    • 16.2.1 U.S.
    • 16.2.2 CANADA
    • 16.2.3 MEXICO
  • 16.3 ASIA-PACIFIC
    • 16.3.1 JAPAN
    • 16.3.2 CHINA
    • 16.3.3 SOUTH KOREA
    • 16.3.4 INDIA
    • 16.3.5 AUSTRALIA
    • 16.3.6 SINGAPORE
    • 16.3.7 MALAYSIA
    • 16.3.8 THAILAND
    • 16.3.9 INDONESIA
    • 16.3.10 PHILIPPINES
    • 16.3.11 NEW ZEALAND
    • 16.3.12 VIETNAM
    • 16.3.13 REST OF ASIA-PACIFIC
  • 16.4 EUROPE
    • 16.4.1 GERMANY
    • 16.4.2 U.K.
    • 16.4.3 FRANCE
    • 16.4.4 ITALY
    • 16.4.5 SPAIN
    • 16.4.6 DENMARK
    • 16.4.7 NETHERLANDS
    • 16.4.8 SWITZERLAND
    • 16.4.9 POLAND
    • 16.4.10 RUSSIA
    • 16.4.11 SWEDEN
    • 16.4.12 BELGIUM
    • 16.4.13 TURKEY
    • 16.4.14 REST OF EUROPE
  • 16.5 SOUTH AMERICA
    • 16.5.1 BRAZIL
    • 16.5.2 ARGENTINA
    • 16.5.3 REST OF SOUTH AMERICA
  • 16.6 MIDDLE EAST & AFRICA
    • 16.6.1 SOUTH AFRICA
    • 16.6.2 U.A.E.
    • 16.6.3 SAUDI ARABIA
    • 16.6.4 OMAN
    • 16.6.5 KUWAIT
    • 16.6.6 REST OF MIDDLE EAST & AFRICA

17 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, COMPANY LANDSCAPE

  • 17.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 17.3 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
  • 17.4 COMPANY SHARE ANALYSIS: EUROPE
  • 17.5 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

18 COMPANY PROFILE

  • 18.1 ROYAL FRIESLANDCAMPINA N.V.
    • 18.1.1 COMPANY SNAPSHOT
    • 18.1.2 REVENUE ANALYSIS
    • 18.1.3 COMPANY SHARE ANALYSIS
    • 18.1.4 PRODUCT PORTFOLIO
    • 18.1.5 RECENT DEVELOPMENTS
  • 18.2 CARGILL, INCORPORATED.
    • 18.2.1 COMPANY SNAPSHOT
    • 18.2.2 REVENUE ANALYSIS
    • 18.2.3 COMPANY SHARE ANALYSIS
    • 18.2.4 PRODUCT PORTFOLIO
    • 18.2.5 RECENT DEVELOPMENT
  • 18.3 INGREDION INCORPORATED
    • 18.3.1 COMPANY SNAPSHOT
    • 18.3.2 REVENUE ANALYSIS
    • 18.3.3 COMPANY SHARE ANALYSIS
    • 18.3.4 PRODUCT PORTFOLIO
    • 18.3.5 RECENT DEVELOPMENT
  • 18.4 BENEO (A SUBSIDIARY OF SUDZUCKER)
    • 18.4.1 COMPANY SNAPSHOT
    • 18.4.2 REVENUE ANALYSIS
    • 18.4.3 COMPANY SHARE ANALYSIS
    • 18.4.4 PRODUCT PORTFOLIO
    • 18.4.5 RECENT DEVELOPMENTS
  • 18.5 FONTERRA CO-OPERATIVE GROUP
    • 18.5.1 COMPANY SNAPSHOT
    • 18.5.2 REVENUE ANALYSIS
    • 18.5.3 COMPANY SHARE ANALYSIS
    • 18.5.4 PRODUCT PORTFOLIO
    • 18.5.5 RECENT DEVELOPMENTS
  • 18.6 BIOSYNTH CARBOSYNTH
    • 18.6.1 COMPANY SNAPSHOT
    • 18.6.2 PRODUCT PORTFOLIO
    • 18.6.3 RECENT DEVELOPMENTS
  • 18.7 COSUCRA
    • 18.7.1 COMPANY SNAPSHOT
    • 18.7.2 PRODUCT PORTFOLIO
    • 18.7.3 RECENT DEVELOPMENTS

  • 18.8 DANA DAIRY GROUP
    • 18.8.1 COMPANY SNAPSHOT
    • 18.8.2 PRODUCT PORTFOLIO
    • 18.8.3 RECENT DEVELOPMENTS
  • 18.9 DEXTRA LABORATORIES LIMITED
    • 18.9.1 COMPANY SNAPSHOT
    • 18.9.2 PRODUCT PORTFOLIO
    • 18.9.3 RECENT DEVELOPMENT
  • 18.10 DUPONT.
    • 18.10.1 COMPANY SNAPSHOT
    • 18.10.2 REVENUE ANALYSIS
    • 18.10.3 PRODUCT PORTFOLIO
    • 18.10.4 RECENT DEVELOPMENTS
  • 18.11 ELICITYL SA
    • 18.11.1 COMPANY SNAPSHOT
    • 18.11.2 PRODUCT PORTFOLIO
    • 18.11.3 RECENT DEVELOPMENT
  • 18.12 GLYCOM A/S
    • 18.12.1 COMPANY SNAPSHOT
    • 18.12.2 PRODUCT PORTFOLIO
    • 18.12.3 RECENT DEVELOPMENT
  • 18.13 GLYCOSYN LLC.
    • 18.13.1 COMPANY SNAPSHOT
    • 18.13.2 PRODUCT PORTFOLIO
    • 18.13.3 RECENT DEVELOPMENTS
  • 18.14 JENNEWEIN BIOTECHNOLOGIE GMBH
    • 18.14.1 COMPANY SNAPSHOT
    • 18.14.2 PRODUCT PORTFOLIO
    • 18.14.3 RECENT DEVELOPMENTS
  • 18.15 NEW FRANCISCO (YUNFU CITY) BIOTECHNOLOGY CORPORATION LIMITED
    • 18.15.1 COMPANY SNAPSHOT
    • 18.15.2 PRODUCT PORTFOLIO
    • 18.15.3 RECENT DEVELOPMENTS
  • 18.16 ROYAL COSUN
    • 18.16.1 COMPANY SNAPSHOT
    • 18.16.2 REVENUE ANALYSIS
    • 18.16.3 APPLICATION PORTFOLIO
    • 18.16.4 RECENT DEVELOPMENT

  • 18.17 TEREOS
    • 18.17.1 COMPANY SNAPSHOT
    • 18.17.2 REVENUE ANALYSIS
    • 18.17.3 PRODUCT PORTFOLIO
    • 18.17.4 RECENT DEVELOPMENT
  • 18.18 ZUCHEM INC.
    • 18.18.1 COMPANY SNAPSHOT
    • 18.18.2 PRODUCT PORTFOLIO
    • 18.18.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

Back to Top
전화 문의
F A Q